Michael Firbank Selected Research

Michael Firbank Research Topics

12	Dementia (Dementias) 10/2023 - 06/2004
10	Cognitive Dysfunction 10/2023 - 01/2020
9	Alzheimer Disease (Alzheimer's Disease) 10/2023 - 02/2015
6	Lewy Body Disease (Lewy Body Dementia) 01/2023 - 01/2020
2	Hallucinations (Hallucination) 10/2023 - 12/2011
2	Disease Progression 01/2022 - 04/2021
2	Vascular Diseases (Vascular Disease) 05/2020 - 01/2020
2	Atrophy 01/2020 - 10/2015
2	Stroke (Strokes) 10/2015 - 03/2011
1	Olfaction Disorders (Cacosmia) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Pathologic Processes 09/2015

9	Biomarkers (Surrogate Marker)IBA 10/2023 - 05/2012
6	Cholinergic Agents (Cholinergics)IBA 10/2023 - 01/2020
3	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2020
2	3-Iodobenzylguanidine (Iobenguane)IBA 01/2023 - 07/2022
2	IodineIBA 01/2023 - 06/2004
2	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2023 - 06/2004
1	adriamycin-14-valerate (AD 48)IBA 10/2023
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Pemetrexed (MTA)FDA Link 10/2015
1	Amyloid beta-PeptidesIBA 09/2015
1	pleiotrophin (HARP)IBA 02/2015
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2011
1	Codon (Codons)IBA 03/2011
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 06/2004

1	Transcranial Magnetic Stimulation 12/2011